Medication-related quality of life among Ethiopian elderly patients with polypharmacy: A cross-sectional study in an Ethiopia university hospital.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
18
06
2017
accepted:
09
03
2019
entrez:
29
3
2019
pubmed:
29
3
2019
medline:
18
12
2019
Statut:
epublish
Résumé
Polypharmacy among older patients has been associated with a decline in their quality of life. We aimed to assess the medication-related quality of life (MRQOL) among older patients with polypharmacy at Gondar University Hospital, Gondar, Ethiopia. A prospective cross-sectional study was carried out among 150 elder patients who had visited the internal medicine ward and ambulatory ward of Gondar referral hospital from March 25 to May 15, 2017, using a validated scale, Medication-Related Quality of Life Scale version 1.0 (MRQoLS-v1.0). A total of 150 older patients with polypharmacy participated in the study with a mean age of 70.06±5.12, andtwo-thirds of the participants (67.3%) were female. The overall prevalence of poor quality of life due to polypharmacy in the current study was found to be three fourth (75.3%) of the participants. Regarding the severity of impairment in MRQoL, Univariate analysis revealed that frequency of hospital visits (COR = 1.34, 95% CI, 1.02-1.77) and medication number (COR = 1.94, 95% CI, 1.33, 2.8) had a statistically significant positive association with the likelihood of having a severe impairment.The multivariate analysis also showed that one unit increase in the number of hospital visits (AOR = 1.45, 95% CI, 1.040-2.024) and medications greater than 5 (AOR = 1.91, 95% CI, 1.29, 2.84) increases 1.45 and 1.91 times the likely hood of posing severe impairment of MRQoL, respectively. As far as poor MRQoL quality of life is concerned, multivariate analysis did not show any significant association between the poor MRQoL;and Sociodemographic and clinical data of patients. The poor QoL associated with medication was very high in this study. Deprescribing should be sought by the health care providers to optimize drug therapy and minimize the polypharmacy related poor quality of life.
Identifiants
pubmed: 30921379
doi: 10.1371/journal.pone.0214191
pii: PONE-D-17-23219
pmc: PMC6438590
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0214191Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Soc Sci Med. 2014 Feb;102:83-93
pubmed: 24565145
Cochrane Database Syst Rev. 2014 Oct 07;(10):CD008165
pubmed: 25288041
J Clin Epidemiol. 2003 Jan;56(1):52-60
pubmed: 12589870
Clin Interv Aging. 2008;3(2):383-9
pubmed: 18686760
Ann Pharmacother. 2009 Dec;43(12):1978-85
pubmed: 19920158
Value Health Reg Issues. 2013 May;2(1):107-117
pubmed: 29702838
Pharmacoepidemiol Drug Saf. 2011 May;20(5):514-22
pubmed: 21308855
Age Ageing. 2001 May;30(3):205-11
pubmed: 11443021
Ther Adv Drug Saf. 2017 Apr;8(4):117-132
pubmed: 28439398
PLoS One. 2015 May 26;10(5):e0128356
pubmed: 26010571
J Am Geriatr Soc. 2013 Mar;61(3):371-9
pubmed: 23452034
Am J Med. 1996 Apr;100(4):428-37
pubmed: 8610730
Am J Geriatr Pharmacother. 2007 Dec;5(4):345-51
pubmed: 18179993
BMC Public Health. 2014 May 07;14:431
pubmed: 24885315
BMC Geriatr. 2017 Jan 14;17(1):19
pubmed: 28088178
Med Clin (Barc). 2010 Mar 13;134(7):303-6
pubmed: 20096892
Aten Primaria. 2001 Jul-Aug;28(3):167-73
pubmed: 11459522
Am J Health Syst Pharm. 2003 Jun 1;60(11):1123-9
pubmed: 12816022
Int J Geriatr Psychiatry. 2009 Jun;24(6):595-601
pubmed: 19031476
Age Ageing. 2010 Jul;39(4):481-7
pubmed: 20513770
Qual Life Res. 1993 Apr;2(2):153-9
pubmed: 8518769
Res Social Adm Pharm. 2016 May-Jun;12(3):438-49
pubmed: 26453002
Aten Primaria. 2003 Mar 31;31(5):285-92; discussion 293-4
pubmed: 12681142
Home Healthc Nurse. 2012 Sep;30(8):474-85; quiz 486-7
pubmed: 22936046
Qual Life Res. 2016 May;25(5):1295-302
pubmed: 26584811
Br J Clin Pharmacol. 2014 Oct;78(4):738-47
pubmed: 24661192
J Clin Epidemiol. 1998 Nov;51(11):903-12
pubmed: 9817107
Eur J Clin Pharmacol. 2016 Sep;72(9):1117-24
pubmed: 27251360
BMJ Open. 2018 Apr 20;8(4):e020590
pubmed: 29678983
PLoS One. 2017 Feb 6;12(2):e0171320
pubmed: 28166266
Qual Life Res. 2008 Dec;17(10):1229-38
pubmed: 18855125
Enferm Clin. 2012 Sep-Oct;22(5):239-46
pubmed: 22902602
Pharm Pract (Granada). 2006 Jul;4(3):103-9
pubmed: 25247007
Pharmacol Res Perspect. 2017 May 31;5(3):e00321
pubmed: 28603638
Maturitas. 2016 Sep;91:115-34
pubmed: 27451330
Qual Life Res. 2015 Nov;24(11):2723-31
pubmed: 26001640
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560